coprelotamab
mAbexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 7, 2011 (NCT04175171)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
ERBB2 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04175171 | Phase 1 | Nov 7, 2011 | Genor BioPharma Co., Ltd., Linear Clinical Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genor BioPharma Co., Ltd. | For profit | 1 | 1 | 1 | 2011 |
| Linear Clinical Research | For profit | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1